In summary, factors regulating TLS formation in epithelial tissues, such as the chemokines CCL19, CCL21 and CXCL13, and the cytokine LTαβ, most likely also contribute to an anti-tumor immune response in several carcinomas/adenocarcinomas. The gene discussed is CCL19; the disease is adenocarcinoma.